Contact

All Stories

  1. Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law

    Article • European Journal of Health Law, April 2022, Brill

    Timo Minssen, Ana Nordberg, Duncan Matthews

  2. Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives

    Article • European Journal of Health Law, April 2022, Brill

    Santa Slokenberga, Timo Minssen, Ana Nordberg

  3. Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development

    Article • January 2020, Springer Science + Business Media

    Ana Nordberg

  4. Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective

    Article • Bioethics, December 2019, Wiley

    Ana Nordberg

  5. Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns

    Article • Journal of Law and the Biosciences, January 2018, Oxford University Press (OUP)

    Ana Nordberg

  6. A “Ray of Hope” for European Stem Cell Patents or “Out of the Smog into the Fog”? An Analysis of Recent European Case Law and How it Compares to the US

    Article • IIC - International Review of Intellectual Property and Competition Law, February 2016, Springer Science + Business Media

    Ana Nordberg

  7. The Impact of “Broccoli II” and “Tomatoes II” on European Patents in Conventional Breeding, GMOs, and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?

    Article • Biotechnology Law Report, June 2015, Mary Ann Liebert Inc

    Ana Nordberg